Chowist Web Search

Search results

1. Results From The WOW.Com Content Network

2. 84 best discounts for ages 50+: Where to save money for ... - AOL

   www.aol.com/finance/best-senior-discounts...

   Read the fine print before you pick a rental company, and make sure they take your discount off the base rate for maximum savings. Ages 50 and older. Hertz — 20% off base rate. Sixt — 5% ...

3. Apixaban - Wikipedia

   en.wikipedia.org/wiki/Apixaban

   Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. [6] [7] [8] Specifically, it is used to prevent blood clots following hip or knee replacement and in those with a history of ...

4. The 75 Best Senior Discounts and Where to Find Them - AOL

   www.aol.com/75-best-senior-discounts-where...

   Company. Discount. Age. Albertsons. 10%; first Wednesday of month. 55 and older. GET DETAILS. Fred Meyer. 5%; first Tuesday of month. 55 and older. GET DETAILS ...

5. US government sends initial offers for Medicare drug price cuts

   www.aol.com/news/us-government-sends-initial...

   The initial offers have been sent to manufacturers of 10 high-cost medicines, which include Bristol Myers Squibb and Pfizer's blood thinner Eliquis, Merck & Co's diabetes drug Januvia and Johnson ...

6. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Medical use. Direct factor Xa inhibitors include rivaroxaban, apixaban and edoxaban, and are types of direct oral anticoagulant (DOAC), which are blood thinning drugs, one of the classes of antithrombotic drugs. [4] [5] [6] They are commonly prescribed to treat and prevent blood clots in veins, prevent stroke and embolism in people with non ...

7. Discovery and development of direct Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   Discovery and development of direct Xa inhibitors. Four drugs from the class of direct Xa inhibitors are marketed worldwide. Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States ...